Moreover, we observed strong expression of SESN2 protein in RL-92-5 cells derived from a moderately differentiated G2 endometrial adenosquamous carcinoma representing type I [36]. The gene discussed is SESN2; the disease is endometrial adenosquamous carcinoma.